Skip to main content
logo
Invex Therapeutics Ltd (ASX:IXC)
Australia flag Australia · Delayed Price · Currency is AUD
0.1150
0.00 (0.00%)
Sep 16, 2026, 12:33 PM AEST

Invex Therapeutics Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
1.525.386.0322.4729.34
Short-Term Investments
2.5----
Cash & Short-Term Investments
4.025.386.0322.4729.34
Cash Growth
-25.28%-10.79%-73.19%-23.41%-10.32%
Other Receivables
0.050.090.090.330.15
Receivables
0.050.090.090.330.15
Total Current Assets
4.065.476.1222.829.49
Total Assets
4.065.476.1222.829.49

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
0.130.170.011.140.14
Accrued Expenses
0.020.050.430.430.87
Total Current Liabilities
0.150.220.431.571
Total Liabilities
0.150.220.431.571

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
22.4122.4122.4136.4136.41
Retained Earnings
-21.04-19.7-19.22-17.58-9.83
Comprehensive Income & Other
2.532.532.52.41.9
Shareholders' Equity
3.915.255.6921.2328.48
Total Liabilities & Equity
4.065.476.1222.829.49

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash (Debt)
4.025.386.0322.4729.34
Net Cash Growth
-25.28%-10.79%-73.19%-23.41%-10.32%
Net Cash Per Share
0.050.070.080.300.39
Filing Date Shares Outstanding
75.1575.1575.1575.1575.15
Total Common Shares Outstanding
75.1575.1575.1575.1575.15
Working Capital
3.915.255.6921.2328.48
Book Value Per Share
0.050.070.080.280.38
Tangible Book Value
3.915.255.6921.2328.48
Tangible Book Value Per Share
0.050.070.080.280.38